Harvard Bioscience (HBIO)
Harvard Bioscience Revenues: 28.32M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
HBIO Revenues Rankings
| Overall | 26th percentile | 3238 of 4425 |
| Sector | 51st percentile | 230 of 470 in Healthcare |
| Industry | 53rd percentile | 31 of 67 in Medical Instruments & Supplies |
HBIO Revenues Range, Past 5 Years
| Minimum | 18.05M | Jun 2009 |
| Maximum | 29.52M | Dec 2010 |
| Average | 24.17M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these HBIO related companies
HBIO News
$HBIO Harvard and MIT team up to change the online education game http://stks.co/3luV
about 19 days ago by ericjones12398
about 19 days ago by ericjones12398
Listen to $HBIO Q1 2012 earnings call - live at 11:00 AM, ondemand after - http://stks.co/3eOH
about 26 days ago by earningscast
about 26 days ago by earningscast
HBIO Reports First Quarter 2012 Revenue Growth of 8% Over First Quarter 2011
May 03, 7:00AM GlobeNewswire
May 03, 7:00AM GlobeNewswire
Harvard Bioscience, Inc. Schedules First Quarter 2012 Conference Call for May 3, 2012
Apr 30, 10:21PM GlobeNewswire
Apr 30, 10:21PM GlobeNewswire
$WRLS $HBIO $TINY $ACFN $CNTY to present at SeeThruEquity Small Cap Investor Conf, 6/5-Cornell Club NYC http://stks.co/3a8I
about 29 days ago by ATandon_STE
about 29 days ago by ATandon_STE
$HBIO to present at SeeThruEquity Small Inv Conf 6/5, Cornell Club in NYC http://stks.co/3P4h $ABT $BDX $TMO $BIO $MR $COV
about 41 days ago by ATandon_STE
about 41 days ago by ATandon_STE
$HBIO put out earnings yesterday, we'll be issuing our research update shortly at http://stks.co/2ebZ $MRK $CNMD $COV $JNJ $NVS $PFE
about 88 days ago by ATandon_STE
about 88 days ago by ATandon_STE
$HBIO forms bearish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/2eR8
about 88 days ago by RecogniaEvents
about 88 days ago by RecogniaEvents
$HBIO forms bearish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/2eHQ
about 88 days ago by RecogniaEvents
about 88 days ago by RecogniaEvents
$HBIO forms bearish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/2dtH
about 89 days ago by RecogniaEventsTest
about 89 days ago by RecogniaEventsTest
Listen to $HBIO Q4 2011 earnings call - live at 11:00 AM, ondemand after - http://stks.co/2dGc
about 89 days ago by earningscast
about 89 days ago by earningscast
Harvard Bioscience, Inc. (HBIO) Reports Q4 Earnings of $0.07; Guides FY12, Q1 EPS
Mar 01, 7:08AM Street Insider
Mar 01, 7:08AM Street Insider
Harvard Bioscience, Inc. Schedules Fourth Quarter 2011 Conference Call for March 1, 2012
Feb 27, 4:24PM GlobeNewswire
Feb 27, 4:24PM GlobeNewswire
Harvard Bioscience, Inc. Announces Participation in the Regenerative Medicine Insight Track at the Biotech Showcase
Jan 09, 3:24PM GlobeNewswire
Jan 09, 3:24PM GlobeNewswire
Harvard Bioscience's "InBreath" Bioreactor Used in World's Second Successful Synthetic Trachea Transplant
Nov 29, 7:30AM GlobeNewswire
Nov 29, 7:30AM GlobeNewswire
Harvard Bioscience, Inc. Schedules Third Quarter 2011 Conference Call for November 3, 2011
Oct 28, 5:23PM GlobeNewswire
Oct 28, 5:23PM GlobeNewswire
$HBIO Harvard Bioscience Spiking Higher on DealReporter Story Sayin Company is for Sale
about 222 days ago by Benzinga
about 222 days ago by Benzinga
HBIO President David Green to Present at the UBS 2011 Global Life Sciences Conference
Sep 12, 8:00AM GlobeNewswire
Sep 12, 8:00AM GlobeNewswire
SeeThruEquity (http://stks.co/17F) releases 2Q11 updates for $HNRG Hallador Energy, $INTX Intersections, and $HBIO Harvard Bioscience
about 279 days ago by Ajtandon1
about 279 days ago by Ajtandon1
$HBIO acquires Coulbourn Instruments manufacturer of systems used in behavioral research mkt expect acquisition to be immediately accretive
about 645 days ago by drakoncapital
about 645 days ago by drakoncapital
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| HBIO | 3.60 | +0.00 | +0.00% | 103.50M |
| HBI | 27.89 | +0.84 | +3.11% | 2.639B |
| HBHC | 30.48 | +0.76 | +2.56% | 2.549B |
| HBC | 40.37 | +0.14 | +0.35% | |
| HBAN | 6.64 | +0.18 | +2.79% | 5.593B |
| GWR | 51.44 | -0.22 | -0.43% | 2.194B |
| GVP | 2.29 | -0.07 | -2.97% | 43.33M |
| GVI | 111.69 | +0.12 | +0.11% | |
| GVA | 23.11 | +0.21 | +0.92% | 886.00M |
| GV | 1.51 | +0.03 | +2.03% | 37.67M |
